Daily Archives: June 22, 2018

mention the biphasic pattern of bacterial killing plus the figure from ( Honeyborne et al.,2016) and the presence of two distinct population of Mtb 4- transcriptomic signature profiling plus the benefit of transcritomic profiling

INTRODUCTION: 1-MOLECULAR BACTERIAL LOAD ASSAY (MBL) 2-THE URGET NEED OF NEW DRUG TO TREAT TUBERCULOSIS AND MULTI DRUG RESISTANT TB and the three main approaches to TB drug development (Evangelopoulos & Waddell, 2016) 3- physiological states of Mycobacterium tuberculosis (Garton et al.,2008; Baer et al., 2015) and also mention the biphasic pattern of bacterial killing plus the figure from ( Honeyborne et al.,2016) and the presence of two distinct population of Mtb (Carton et al.,2008) 4- transcriptomic signature profiling (Honeyborne et al.,2016) plus the benefit of transcritomic profiling (Evangelopoulus & Waddell, 2016) 5- Para-aminosalicylic acid (Donald & Diacon, 2015) (Charkraborty et al.,2013) Results chapter: 1- As they stated that the MBL Assay is specific for mycobacterium tuberculosis, I did try it on a number of non-tuberculous mycobacteria which….

MEASURE AND COMPARE THE MBL ASSAY AND CFU IN THE PRESENCE AND ABSENCE OF HALF MIC RIFAMPICIN

INTRODUCTION: 1-MOLECULAR BACTERIAL LOAD ASSAY (MBL) 2-THE URGET NEED OF NEW DRUG TO TREAT TUBERCULOSIS AND MULTI DRUG RESISTANT TB and the three main approaches to TB drug development (Evangelopoulos & Waddell, 2016) 3- physiological states of Mycobacterium tuberculosis (Garton et al.,2008; Baer et al., 2015) and also mention the biphasic pattern of bacterial killing plus the figure from ( Honeyborne et al.,2016) and the presence of two distinct population of Mtb (Carton et al.,2008) 4- transcriptomic signature profiling (Honeyborne et al.,2016) plus the benefit of transcritomic profiling (Evangelopoulus & Waddell, 2016) 5- Para-aminosalicylic acid (Donald & Diacon, 2015) (Charkraborty et al.,2013) Results chapter: 1- As they stated that the MBL Assay is specific for mycobacterium tuberculosis, I did try it on a number of non-tuberculous mycobacteria which….

THE URGENT NEED OF NEW DRUG TO TREAT TUBERCULOSIS AND MULTI DRUG RESISTANT TB

INTRODUCTION: 1-MOLECULAR BACTERIAL LOAD ASSAY (MBL) 2-THE URGET NEED OF NEW DRUG TO TREAT TUBERCULOSIS AND MULTI DRUG RESISTANT TB and the three main approaches to TB drug development (Evangelopoulos & Waddell, 2016) 3- physiological states of Mycobacterium tuberculosis (Garton et al.,2008; Baer et al., 2015) and also mention the biphasic pattern of bacterial killing plus the figure from ( Honeyborne et al.,2016) and the presence of two distinct population of Mtb (Carton et al.,2008) 4- transcriptomic signature profiling (Honeyborne et al.,2016) plus the benefit of transcritomic profiling (Evangelopoulus & Waddell, 2016) 5- Para-aminosalicylic acid (Donald & Diacon, 2015) (Charkraborty et al.,2013) Results chapter: 1- As they stated that the MBL Assay is specific for mycobacterium tuberculosis, I did try it on a number of non-tuberculous mycobacteria which….